Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Anti-Cancer Agents in Medicinal Chemistry|January 18, 2011
Discovery of allosteric inhibitors of kinesin spindle protein (KSP) for the treatment of taxane-refractory cancer: MK-0731 and analogsChristopher D Cox, Robert M Garbaccio
Journal of Medicinal Chemistry|August 29, 2015
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of InsomniaAnthony J Roecker, Christopher D Cox, Paul J Coleman
Current Topics in Medicinal Chemistry|January 26, 2011
Discovery of dual orexin receptor antagonists (DORAs) for the treatment of insomniaPaul J Coleman, Christopher D Cox, Anthony J Roecker
Journal of Cellular and Molecular Medicine|April 15, 2022
Stem Cell-based therapies for COVID-19-related acute respiratory distress syndromeHoi Wa Ngai, Dae Hong Kim, Mohamed Hammad, et al.
Journal of Neurotrauma|December 9, 2008
Dicyclomine, an M1 muscarinic antagonist, reduces biomarker levels, but not neuronal degeneration, in fluid percussion brain injuryChristopher D Cox, Eric J West, Ming Cheng Liu, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 21, 2011
Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humansFrank R Sharp, Glen C Jickling, Boryana Stamova, et al.
Journal of Computer-Aided Molecular Design|February 4, 2014
Shaping suvorexant: application of experimental and theoretical methods for driving synthetic designsGeorgia McGaughey, Christopher I Bayly, Christopher D Cox, et al.
Bioorganic & Medicinal Chemistry Letters|May 2, 2009
Conformational analysis of N,N-disubstituted-1,4-diazepane orexin receptor antagonists and implications for receptor bindingChristopher D Cox, Georgia B McGaughey, Michael J Bogusky, et al.
Pageof 4